Our Story
An endeavour towards quality at-home healthcare
Born from Stanford-inspired BioDesign Innovation course at the University of Melbourne, Vysum was founded by passionate graduates in 2022. The team interviewed and surveyed 500 patients and clinicians and identified a major gap in ophthalmic care: the low compliance rate for ophthalmic treatment and the lack of patient progress data to clinicians.
Working with engineers, clinicians and patients, the team at Vysum is developing an EyeCare device for better treatment delivery and mangement. They endeavour to provide quality at-home healthcare and empower users with digital health technologies.
Founder and Directors
Lorace Zhang
Founder CEO
Operations, Product Development, and Relationships
Lorace holds a Bachelor's degree in Biomedicine with Honors and a Master's degree in Biomedical Engineering from the University of Melbourne. She has experience in research, human anatomy and physiology, as well as data science.
As the face of Vysum, Lorace is responsible for managing the company's operations, overseeing product development, managing stakeholders, and contributing to the company's strategic direction.
Stephen Ho
Co-Director, Investor
Commercial Strategy, Management, and Governance
Stephen is an accomplished executive with expertise in technology, marketing, and business management, gained from his roles at John Hollands, Leightons, Foster Wheeler, IHI Corp Japan, and BHP, where he held senior management positions for 24 years.
As a technology entrepreneur and angel investor, Stephen co-wrote a standard for sustainability development that earned recognition from the Singapore government. He has also served as a former Director of the Australian Chamber of International Trade.
Team Members
Li Hoo
Optometrist
Clinical Validation and Development
Li obtained her Bachelor of Optometry, Certificate in Ocular Therapeutics, and Certificate in Advanced Contact Lenses from The University of Melbourne.
She has experience practicing optometry in Australia and New Zealand, and currently works in corporate optometry while also serving as a Clinical Educator at The Australian College of Optometry.
Nathan Batham
Mechatronics Engineer
Product Development and User Validation
Nathan is a seasoned industrial designer, mechatronics engineer and product manufacturer. He has experience leading a multidisciplinary team to develop a large-scale medical instrument.
He has helped many medical device startups to turn their concepts to various stages of prototypes and products. Nathan is also an entrepreneur and creator.
Advisors
Prof Jonathan Crowston
Prof Keith Martin
Dr Danial Roshandel
Strategy Advisor
Professor Jonathan Crowston is a Professor of Ophthalmology, Director of the Save Sight Institute Camperdown Campus, and an Adjunct Professor at Duke-NUS Medical School. He has clinical and research interest in glaucoma, and experience in experimental translational research, clinical research, and entrepreneurship.
He co-founded Oculo, which was sold to Revenio in 2021, and is a director of Plano and a medical advisor of Polyactiva. He obtained his PhD at University College London and was Director of the Hamilton Glaucoma Center Basic Research Laboratories at the University of California, Head of Ophthalmology at the University of Melbourne and Director of CERA. He helped to establish the Centre for Vision Research at Duke-NUS.
Clinical Advisor
Usability Advisor
Professor Keith Martin is a clinician-scientist ophthalmologist, Managing Director of the Centre for Eye Research Australia (CERA), and the Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne. As a Principal Investigator at CERA, he focuses on developing new treatments for eye diseases.
Keith co-founded Quethera and Ikarovec and serves as a Director for Enlighten Imaging and Mirugen. He earned his Doctor of Medicine degree from Cambridge and Oxford universities. He served as a consultant ophthalmologist at the Cambridge University Hospitals NHS Foundation Trust. Keith is the immediate Past President and a Governor of the World Glaucoma Association and is currently the President of the Australia and New Zealand Glaucoma Society.
Dr. Danial Roshandel is a distinguished clinician-scientist ophthalmologist with extensive clinical expertise in cornea and ocular surface diseases, complemented by research background in clinical ophthalmology.
He completed his ophthalmology training at Shahid Beheshti University of Medical Sciences, where he was appointed as Assistant Professor of Ophthalmology.
He earned his PhD in visual science from The University of Western Australia and is currently a postdoctoral research fellow at the Centre for Ophthalmology and Visual Science, Lions Eye Institute, and an Adjunct Research Fellow at the University of Western Australia.